Quick Answer
Healthcare Triangle, Inc. reported R&D Expense of $429.0 thousand for fiscal year 2024.
Healthcare Triangle, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $429.0K | -46.3% |
| 2023 | $799.0K | -86.6% |
| 2022 | $5.95M | +13.3% |
| 2021 | $5.26M | +201.6% |
| 2020 | $1.74M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $59.0K | -66.3% | +7.3% |
| June 30, 2025 | $55.0K | -73.4% | -61.8% |
| March 31, 2025 | $144.0K | +13.4% | -17.7% |
| September 30, 2024 | $175.0K | +224.1% | -15.5% |
| June 30, 2024 | $207.0K | +102.9% | +63.0% |
| March 31, 2024 | $127.0K | -76.4% | +135.2% |
| September 30, 2023 | $54.0K | -96.3% | -47.1% |
| June 30, 2023 | $102.0K | -84.2% | -81.1% |
- Healthcare Triangle, Inc. showed a decrease of -46.3% in R&D Expense compared to the prior fiscal year.
- Over the 2020–2024 period, Healthcare Triangle, Inc.’s r&d expense has declined by 75.4% (from $1.74 million to $429.0 thousand).
- The most recent figure is from Healthcare Triangle, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: